The Chan Zuckerberg Initiative (CZI) has funded five projects, totaling $750,000, to utilize single-cell technologies for understanding COVID-19 disease progression. One key project, co-led by Alex K. Shalek at the Broad Institute, focuses on how pediatric airways respond to SARS-CoV-2. These initiatives aim to generate crucial single-cell biology datasets to identify susceptible cell types, track viral infection, and map disease progression. This research is profoundly important as it leverages the Shalek Lab’s expertise in single-cell analysis to provide high-resolution insights into COVID-19 mechanisms. The open sharing of all generated data through platforms like CZ CELLxGENE further accelerates global scientific collaboration, enabling rapid identification of potential therapeutic targets and ultimately contributing to more effective strategies against the pandemic.
Read more here.